Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sayaka Funabashi"'
Autor:
Yu Kataoka, Satoshi Kitahara, Sayaka Funabashi, Hisashi Makino, Masaki Matsubara, Miki Matsuo, Yoko Omura-Ohata, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Tsutomu Tomita, Kyoko Honda-Kohmo, Michio Noguchi, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kiminori Hosoda, Stephen J. Nicholls, Satoshi Yasuda, Teruo Noguchi
Publikováno v:
Atherosclerosis Plus, Vol 56, Iss , Pp 1-6 (2024)
Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs modulate diabet
Externí odkaz:
https://doaj.org/article/409a421a06d648bab589ebcb9fd6fd88
Autor:
Sayaka Funabashi, Yu Kataoka, Mika Hori, Masatsune Ogura, Takahito Doi, Yoshiaki Morita, Eri Kiyoshige, Kunihiro Nishimura, Teruo Noguchi, Mariko Harada‐Shiba
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background The atherogenic characteristics of heterozygous familial hypercholesterolemia (HeFH) increase the risk of premature atherosclerotic cardiovascular disease including not only coronary artery disease but ischemic stroke. Asymptomatic intracr
Externí odkaz:
https://doaj.org/article/5ff075290af440fdbd969ffd83c464e8
Autor:
Sayaka Funabashi, MD, Yu Kataoka, MD, PhD, Mika Hori, PhD, Masatsune Ogura, MD, PhD, Yuriko Nakaoku, MD, PhD, Kunihiro Nishimura, MD, PhD, Takahito Doi, MD, PhD, Ryo Nishikawa, MD, Kosuke Tsuda, MD, Teruo Noguchi, MD, PhD, Mariko Harada-Shiba, MD, PhD
Publikováno v:
JACC: Asia, Vol 1, Iss 2, Pp 245-255 (2021)
Background: The International Atherosclerosis Society (IAS) has proposed “severe familial hypercholesterolemia” (FH) as a phenotype with the highest cardiovascular risk. However, whether this criteria could appropriately stratify a high-risk Japa
Externí odkaz:
https://doaj.org/article/919678c5992f4a909f394bdd76e7ac22
Autor:
Sayaka Funabashi, Yu Kataoka, Mika Hori, Masatsune Ogura, Takahito Doi, Teruo Noguchi, Mariko Harada‐Shiba
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 16 (2022)
Background Heterozygous familial hypercholesterolemia (HeFH) more likely exhibits extensive atherosclerotic disease at multiple vascular beds. Lipoprotein(a) (Lp(a)) is an atherogenic lipoprotein that elevates HeFH‐related atherosclerotic cardiovas
Externí odkaz:
https://doaj.org/article/692fe8f6541d47f9afc71ce1c8560f95
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 29:795-807
Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder that elevates low-density lipoprotein cholesterol and increases the risk of premature atherosclerotic cardiovascular disease (ASCVD). However, despite their atherogenic lipid pro
Autor:
Sayaka Funabashi, Takashi Kohno, Takato Mohri, Shinsuke Takeuchi, Toshinori Minamishima, Kenichi Yokoyama
Publikováno v:
Circulation Reports. 5:99-100
Autor:
Mariko Harada-Shiba, Yuriko Nakaoku, Yu Kataoka, Teruo Noguchi, Ryo Nishikawa, Sayaka Funabashi, Mika Hori, Kunihiro Nishimura, Takahito Doi, Kosuke Tsuda, Masatsune Ogura
Publikováno v:
JACC: Asia, Vol 1, Iss 2, Pp 245-255 (2021)
Background: The International Atherosclerosis Society (IAS) has proposed “severe familial hypercholesterolemia” (FH) as a phenotype with the highest cardiovascular risk. However, whether this criteria could appropriately stratify a high-risk Japa
Incessant non-sustained ventricular tachycardia immediately after MitraClip placement: a case report
Publikováno v:
European Heart Journal - Case Reports. 6
Background MitraClip therapy has become an alternative therapy for primary and secondary mitral regurgitation (MR) in patients at high surgical risk. However, this procedure is associated with several complications. Case summary The patient was a 93-
Autor:
Teruo Noguchi, Osami Kawarada, Mitsuyo Mizuseki, Sayaka Funabashi, Takeshi Yagyu, Masanori Asakura, Masafumi Kitakaze, Satoshi Yasuda, Kikuko Ohshima, Koko Asakura, Kaori Onda, Shin Ito, Mayumi Fukuda-Doi, Haruko Yamamoto
Publikováno v:
Circulation Reports
Background: Endovascular treatment with balloon angioplasty plays a major role in revascularization of below-the-knee (BTK) arteries in patients with critical limb ischemia (CLI). However, with severely calcified lesions, achieving optimal revascular
Autor:
Yasuhide Asaumi, Yasuhiro Hamatani, Satoshi Yasuda, Takeshi Aiba, Naotsugu Iwakami, Sayaka Funabashi, Kazunori Omote, Hiroki Nakano, Toshiyuki Nagai, Yasuyuki Honda, Kengo Kusano, Kunihiro Nishimura, Hisao Ogawa, Michikazu Nakai, Teruo Noguchi, Satoshi Honda, Toshihisa Anzai, Hiroyuki Yokoyama
Publikováno v:
European Heart Journal. Acute Cardiovascular Care. 9:429-436
Background: The prognostic significance of urinary N-acetyl-β-D-glucosamidase in acute heart failure has not been fully elucidated. Accordingly, this study investigated whether urinary N-acetyl-β-D-glucosamidase could be associated with subsequent